Cytosorbents Corp (15)
Browse by Contract Category
Contracts
-
Third Amendment to the Amended and Restated Loan and Security Agreement, dated December 4, 2020
(Filed With SEC on December 10, 2020)
-
Nineteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated April 16, 2020
(Filed With SEC on August 4, 2020)
-
Employment Agreement by and between the Company and Efthymios Deliargyris, M.D., dated April 12, 2020
(Filed With SEC on April 27, 2020)
-
Amendment No. 1 to Open Market Sale AgreementSM, dated as of April 20, 2020, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc
(Filed With SEC on April 20, 2020)
-
Exclusive Distribution Agreement, dated as of December 15, 2014, by and between CytoSorbents Europe GmbH and Aferetica s.r.l
(Filed With SEC on March 7, 2019)
-
Underwriting Agreement, by and among the Company and the Underwriters, dated as of July 21, 2020
(Filed With SEC on July 22, 2020)
-
Description of Capital Stock of CytoSorbents Corporation
(Filed With SEC on March 5, 2020)
-
Separation Agreement and Release, dated December 9, 2019, by and between CytoSorbents Corporation and Dr. Eric Mortensen
(Filed With SEC on December 12, 2019)
-
Eighteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated January 4, 2019
(Filed With SEC on August 6, 2019)
-
Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Phillip P. Chan
(Filed With SEC on August 5, 2019)
-
Amended and Restated Employment Agreement, dated as of July 30 2019, by and between CytoSorbents Medical, Inc. and Vincent Capponi
(Filed With SEC on August 5, 2019)
-
Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Kathleen P. Bloch
(Filed With SEC on August 5, 2019)
-
First Amendment to the Amended and Restated Loan and Security Agreement
(Filed With SEC on August 5, 2019)
-
Open Market Sale AgreementSM, dated July 9, 2019, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc
(Filed With SEC on July 9, 2019)
-
Amendment to Exclusive Distribution Agreement, dated December 15, 2015, by and between CytoSorbents Europe GmbH and Aferetica s.r.l
(Filed With SEC on March 7, 2019)